JP2022515140A5 - - Google Patents
Info
- Publication number
- JP2022515140A5 JP2022515140A5 JP2021535612A JP2021535612A JP2022515140A5 JP 2022515140 A5 JP2022515140 A5 JP 2022515140A5 JP 2021535612 A JP2021535612 A JP 2021535612A JP 2021535612 A JP2021535612 A JP 2021535612A JP 2022515140 A5 JP2022515140 A5 JP 2022515140A5
- Authority
- JP
- Japan
- Prior art keywords
- modified
- modified oligonucleotide
- compound according
- nucleosides
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163353A JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862783997P | 2018-12-21 | 2018-12-21 | |
| US62/783,997 | 2018-12-21 | ||
| PCT/US2019/068040 WO2020132558A1 (en) | 2018-12-21 | 2019-12-20 | Compounds and methods for reducing pmp22 expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163353A Division JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515140A JP2022515140A (ja) | 2022-02-17 |
| JP2022515140A5 true JP2022515140A5 (https=) | 2022-12-14 |
| JP7561129B2 JP7561129B2 (ja) | 2024-10-03 |
Family
ID=71101859
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535612A Active JP7561129B2 (ja) | 2018-12-21 | 2019-12-20 | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
| JP2024163353A Pending JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163353A Pending JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220112503A1 (https=) |
| EP (1) | EP3897837A4 (https=) |
| JP (2) | JP7561129B2 (https=) |
| WO (1) | WO2020132558A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202006528XA (en) | 2018-01-12 | 2020-08-28 | Bristol Myers Squibb Co | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
| CN120310791A (zh) | 2018-01-12 | 2025-07-15 | 百时美施贵宝公司 | 靶向α-突触核蛋白的反义寡核苷酸及其用途 |
| EP4168549A4 (en) * | 2020-06-19 | 2024-10-09 | Ionis Pharmaceuticals, Inc. | COMPOUNDS AND METHODS FOR PMP22 MODULATION |
| US20240318172A1 (en) * | 2020-12-01 | 2024-09-26 | Research Institute At Nationwide Children's Hospital | Products and methods for inhibition of expression of peripheral myelin protein-22 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198983A1 (en) * | 2002-02-01 | 2003-10-23 | Affymetrix, Inc. | Methods of genetic analysis of human genes |
| ATE459886T1 (de) * | 2003-07-11 | 2010-03-15 | Robert Zeillinger | Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom |
| WO2012177639A2 (en) * | 2011-06-22 | 2012-12-27 | Alnylam Pharmaceuticals, Inc. | Bioprocessing and bioproduction using avian cell lines |
| RS62672B1 (sr) * | 2015-04-03 | 2021-12-31 | Univ Massachusetts | Oligonukleotidna jedinjenja za tretman preeklampsije i drugih angiogenskih poremećaja |
| ES2903394T3 (es) * | 2015-12-14 | 2022-04-01 | Cold Spring Harbor Laboratory | Composiciones para el tratamiento de la retinitis pigmentosa 13 |
| WO2017156242A1 (en) * | 2016-03-09 | 2017-09-14 | Ionis Pharmaceuticals, Inc. | Methods and compositions for inhibiting pmp22 expression |
| KR101889072B1 (ko) * | 2017-09-15 | 2018-08-16 | 한국생명공학연구원 | 디지털 PCR을 이용한 유전성 강직성 대마비(Hereditary spastic paraplegia, HSP) 관련 유전자 SPG4의 거대결손 검증법 |
-
2019
- 2019-12-20 JP JP2021535612A patent/JP7561129B2/ja active Active
- 2019-12-20 US US17/416,392 patent/US20220112503A1/en active Pending
- 2019-12-20 WO PCT/US2019/068040 patent/WO2020132558A1/en not_active Ceased
- 2019-12-20 EP EP19899128.3A patent/EP3897837A4/en active Pending
-
2024
- 2024-09-20 JP JP2024163353A patent/JP2025000717A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515140A5 (https=) | ||
| JP2022518929A5 (https=) | ||
| JP2021530204A5 (https=) | ||
| CN110268060B (zh) | α-1抗胰蛋白酶(AAT)RNAi物质、包含AAT RNAi物质的组合物和使用方法 | |
| CN111527207B (zh) | GalNAc衍生物 | |
| CN105264091B (zh) | 用于调节tau表达的组合物和方法 | |
| CN110079524B (zh) | 用于调节hbv和ttr表达的组合物和方法 | |
| JP7557469B2 (ja) | Ａｐｐの発現を低減するための化合物及び方法 | |
| JP2023134635A (ja) | Ｌｒｒｋ２発現を低減するための化合物及び方法 | |
| JP7197463B2 (ja) | Ｓｍｎ２の調節のための化合物及び方法 | |
| JP2023536472A5 (https=) | ||
| JP7455831B2 (ja) | プリオン発現を低減するための化合物及び方法 | |
| JP2018150344A5 (https=) | ||
| JP7834872B2 (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）発現の調節 | |
| JP2022515193A5 (https=) | ||
| JP2024539596A5 (https=) | ||
| JP7446443B2 (ja) | Ｓｍｎ２を調節するための化合物及び方法 | |
| KR20080065617A (ko) | 글루코코티코이드 수용체 발현의 조절 | |
| JPH10507635A (ja) | 遺伝子発現をダウンレギュレートするための２’−置換オリゴヌクレオチドの使用 | |
| JP2019525918A5 (https=) | ||
| JP2022509625A5 (https=) | ||
| JP2022520986A5 (https=) | ||
| JP2022527105A5 (https=) | ||
| JP2024523363A5 (https=) | ||
| JP2024523363A (ja) | Ｉｆｎａｒ１の発現を低減するための化合物及び方法 |